Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion.
暂无分享,去创建一个
[1] E. El-Omar,et al. Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families , 2008, Clinical Cancer Research.
[2] K. Hardie,et al. Functional association between the Helicobacter pylori virulence factors VacA and CagA. , 2008, Journal of medical microbiology.
[3] S. Wessler,et al. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility , 2007, Oncogene.
[4] J. Puente,et al. Heterogeneity in the Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its Association with Diversity in the cagA Gene , 2007, Infection and Immunity.
[5] S. Brandt,et al. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. , 2007, Gastroenterology.
[6] K. Robinson,et al. The inflammatory and immune response to Helicobacter pylori infection. , 2007, Best practice & research. Clinical gastroenterology.
[7] Nayoung Kim,et al. Analysis of the 3′ Variable Region of the cagA Gene of Helicobacter pylori Isolated in Koreans , 2007, Digestive Diseases and Sciences.
[8] D. Sgouras,et al. Strategy To Characterize the Number and Type of Repeating EPIYA Phosphorylation Motifs in the Carboxyl Terminus of CagA Protein in Helicobacter pylori Clinical Isolates , 2006, Journal of Clinical Microbiology.
[9] M. Hatakeyama. Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis , 2006, International journal of cancer.
[10] N. Ahmed,et al. Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island , 2006, BMC Genomics.
[11] T. Azuma,et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. , 2006, Gastroenterology.
[12] J. Atherton,et al. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. , 2006, Annual review of pathology.
[13] M. Blaser,et al. Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin‐8 , 2006, Cellular microbiology.
[14] S. Brandt,et al. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Shu Zheng,et al. Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patients. , 2005, World journal of gastroenterology.
[16] Rachael J. Thomas,et al. Tyrosine Phosphorylation of CagA from Chinese Helicobacter pylori Isolates in AGS Gastric Epithelial Cells , 2005, Journal of Clinical Microbiology.
[17] J. Atherton,et al. Simple Method for Determination of the Number of Helicobacter pylori CagA Variable-Region EPIYA Tyrosine Phosphorylation Motifs by PCR , 2005, Journal of Clinical Microbiology.
[18] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[19] M. Kidd,et al. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. , 2004, Gastroenterology.
[20] N. Ahmed,et al. Microevolution between paired antral and paired antrum and corpus Helicobacter pylori isolates recovered from individual patients. , 2004, Journal of medical microbiology.
[21] Takeshi Azuma,et al. Helicobacter pylori CagA Induces Ras-independent Morphogenetic Response through SHP-2 Recruitment and Activation* , 2004, Journal of Biological Chemistry.
[22] T. Azuma,et al. Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. , 2004, The Journal of infectious diseases.
[23] M. Blaser,et al. Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype. , 2003, The Journal of infectious diseases.
[24] Megumi Higuchi,et al. Attenuation of Helicobacter pylori CagA·SHP-2 Signaling by Interaction between CagA and C-terminal Src Kinase* , 2003, The Journal of Biological Chemistry.
[25] Takeshi Azuma,et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] Douglas J Hilton,et al. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. , 2002, Biochemistry.
[27] C. O'Morain,et al. Identification of a new segment involved in cagA 3' region variation of Helicobacter pylori. , 2002, FEMS immunology and medical microbiology.
[28] M. Selbach,et al. Src Is the Kinase of the Helicobacter pylori CagA Protein in Vitro and in Vivo * , 2002, The Journal of Biological Chemistry.
[29] R. Rappuoli,et al. c‐Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs , 2002, Molecular microbiology.
[30] Takeshi Azuma,et al. SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.
[31] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[32] D. Graham,et al. Variants of the 3′ Region of the cagA Gene inHelicobacter pylori Isolates from Patients with DifferentH. pylori-Associated Diseases , 1998, Journal of Clinical Microbiology.
[33] D. Evans,et al. Diversity in the variable region of Helicobacter pylori cagA gene involves more than simple repetition of a 102-nucleotide sequence. , 1998, Biochemical and biophysical research communications.
[34] P. Galle,et al. Diversity of Helicobacter pylori vacA andcagA Genes and Relationship to VacA and CagA Protein Expression, Cytotoxin Production, and Associated Diseases , 1998, Journal of Clinical Microbiology.
[35] M. Upton,et al. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. , 1997, Gastroenterology.
[36] M. Borodovsky,et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Blaser,et al. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL‐8 in gastric epithelial cells , 1995, Molecular microbiology.
[38] M. Blaser,et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.
[39] R. Rappuoli,et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Blaser,et al. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production , 1993, Infection and immunity.
[41] S. Kresovich,et al. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. , 1992, Nucleic acids research.
[42] G. Feng,et al. The Shp-2 tyrosine phosphatase , 2004 .
[43] L. Murray,et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. , 2000, Gastroenterology.